Michael Rosenblatt

Michael Rosenblatt

Director/Board Member at PYC THERAPEUTICS LIMITED

Net worth: 671 663 $ as of 2024-04-29

76 year
Health Technology
Health Services
Consumer Services

Profile

Michael A.
Rosenblatt
is the founder of Theracrine, Inc. (founded in 2006) and Radius Health, Inc. (founded in 2003).
He is currently an Independent Director at Azenta, Inc. (since 2018), a Non-Executive Director at PYC Therapeutics Ltd.
(since 2021), a Director at Ferring Pharmaceuticals, Inc. (since 2016), a Non-Executive Director at Perspectum Ltd., a Director at Ohana Biosciences, Inc. (since 2016), a Director at Cygnal Therapeutics, Inc. (since 2016), a Director at Perspectum Group Ltd., a Senior Advisor at Flagship Pioneering, and an Advisor at PureTech Health LLC.
He has held former positions as a Non-Executive Director at Shire Plc (2008-2008, 2008-2009), a Director at ProScript, Inc., a Director at Project HOPE-The-People-To-People Health Foundation, Inc., a Director at Harvard Mit Health Sciences & Technology (1992-1998), an Independent Director at Axcella Health, Inc. (2022-2023), an Independent Director at Rubius Therapeutics, Inc. (2014-2023), a Director at Cobalt Biomedicine, Inc., the Chief Medical Officer & Executive Vice President at Merck & Co., Inc. (1984-2016), the Chief Medical Officer at Schering-Plough Corp., a Principal at The General Hospital Corp.
(1981-1984), a Senior Vice President-Academic Programs at CareGroup, Inc. (1996-2000), the President at Beth Israel Deaconess Medical Center, Inc. (1996-2003), a Member-Scientific Counselors Board at National Institute of Diabetes & Digestive & Kidney Diseases, a Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC, a Professor at Harvard Medical School, and a Senior Vice President-Research at Merck Sharp & Dohme Corp.
(1984-1992).
He has an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-11 13,042 ( 0.02% ) 671 663 $ 2024-04-29
2023-10-30 0 ( -.--% ) - $ 2023-12-30
2023-06-29 0 ( -.--% ) - $ 2024-04-29

Michael Rosenblatt active positions

CompaniesPositionStart
AZENTA, INC. Director/Board Member 2018-09-04
PYC THERAPEUTICS LIMITED Director/Board Member 2021-03-16
Director/Board Member 2022-02-24
Director/Board Member -
Consultant / Advisor 2021-12-31
Director/Board Member 2015-12-31
Director/Board Member 2015-12-31
Corporate Officer/Principal 2010-12-28
Director/Board Member 2015-12-31
All active positions of Michael Rosenblatt

Former positions of Michael Rosenblatt

CompaniesPositionEnd
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Michael Rosenblatt's experience

Training of Michael Rosenblatt

The Trustees of Columbia University in The City of New York Undergraduate Degree
Harvard Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Rosenblatt's experience

Connections

100 +

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
MERCK & CO., INC.

Health Technology

AZENTA, INC.

Health Services

PYC THERAPEUTICS LIMITED

Health Technology

AXCA HEALPAR

Health Technology

Private companies23

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Molecular Medicine LLC

Health Technology

Health Services

National Institute of Diabetes & Digestive & Kidney Diseases

Government

Health Technology

Technology Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Rosenblatt